Toxicity | Total No. of Patients | 0.25 mL Group | 1 mL Group | ||||
---|---|---|---|---|---|---|---|
 | 0.25 mL | 1 mL | Grade 1 | Grade 2 | Grade 1 | Grade 2 | Grade 3 |
Injection site induration | 11 | 9 | 6 | 5 | 3 | 5 | 1 |
Injection site erythema | 8 | 10 | 6 | 2 | 5 | 4 | 1 |
Injection site pain | 3 | 8 | 1 | 2 | 3 | 5 | Â |
Injection site pruritis | 3 | 2 | 3 | Â | 1 | 1 | Â |
Injection site warmth | 2 | 2 | 1 | 1 | 1 | 1 | Â |
Injection site hematoma | 2 | Â | 2 | Â | Â | Â | Â |
Injection site edema | 1 | 4 | 1 | Â | 2 | 2 | Â |
Injection site discoloration | 1 | 2 | Â | 1 | 2 | Â | Â |
Injection site rash | 1 | 1 | 1 | Â | Â | 1 | Â |
Injection site urticaria | 1 | 1 | 1 | Â | Â | 1 | Â |
Injection site dry skin | 1 | 1 | 1 | Â | 1 | Â | Â |
Injection site ulceration | Â | 3 | Â | Â | 1 | Â | 2* |
Pain | 3 | 1 | 2 | 1 | Â | 1 | Â |
Fatigue | 2 | Â | 1 | 1 | Â | Â | Â |
Fever | 1 | 2 | Â | 1 | 1 | 1 | Â |
Arthralgia | 1 | 1 | 1 | Â | 1 | Â | Â |
Myalgia | 1 | 1 | 1 | Â | 1 | Â | Â |
Anaemia | 1 | 1 | Â | 1 | Â | 1 | Â |